Latest news
CervoMed (NASDAQ: CRVO) details Q2 2026 loss, cash runway and DLB program - Stock TitanStock Titan · Mon, 10 Aug 2026 20:08:17 GMTCervoMed Q2 Results: EPS Misses Estimate, Losses Widen YoY - scanx.tradescanx.trade · Mon, 10 Aug 2026 12:50:42 GMTCervoMed Q2 Results: Net Loss Widens To $6.6M, Seeks DLB Partner - scanx.tradescanx.trade · Mon, 10 Aug 2026 12:50:40 GMTCervoMed to Share Drug Program Progress at Aug. 11 Chat - Stock TitanStock Titan · Wed, 05 Aug 2026 11:30:00 GMT